Literature DB >> 25266050

A new flavanone and other flavonoids from green perilla leaf extract inhibit nitric oxide production in interleukin 1β-treated hepatocytes.

Ayaka Nakajima1, Yuka Yamamoto, Nao Yoshinaka, Mayuri Namba, Hirotaka Matsuo, Tetsuya Okuyama, Emi Yoshigai, Tadayoshi Okumura, Mikio Nishizawa, Yukinobu Ikeya.   

Abstract

A new flavanone, shisoflavanone A (1), and several flavonoids were purified from the ethyl acetate-soluble fraction of green perilla leaves (Perilla frutescens Britton var. crispa form viridis), and their structures were identified. Shisoflavanone A was elucidated as 8-hydroxy-6,7-dimethoxyflavanone based on its spectral data. Other constituents of the ethyl acetate-soluble fraction, i.e. 5,8-dihydroxy-7-methoxyflavanone (2), negletein (5,6-dihydroxy-7-methoxyflavone) (3), luteolin (4), apigenin (5), esculetin (6), and protocatechuic acid (7), were identified. This is the first time that constituents 2, 3, and 6 have been found in green perilla. Shisoflavanone A and the other constituents (except 7) significantly inhibited nitric oxide production in interleukin 1β-stimulated rat hepatocytes, which have been used to monitor the anti-inflammatory effects of herbal constituents. The present findings suggest that these constituents, including shisoflavanone A, may be involved in the anti-inflammatory effects of green perilla leaves.

Entities:  

Keywords:  chemokine; flavanone; flavone; green perilla; nitric oxide

Mesh:

Substances:

Year:  2014        PMID: 25266050     DOI: 10.1080/09168451.2014.962474

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  8 in total

1.  Lignans from guaiac resin decrease nitric oxide production in interleukin 1β-treated hepatocytes.

Authors:  Yuki Nakano; Masaaki Nasu; Mana Kano; Hiroshi Kameoka; Tetsuya Okuyama; Mikio Nishizawa; Yukinobu Ikeya
Journal:  J Nat Med       Date:  2016-10-05       Impact factor: 2.343

2.  Sakuranetin downregulates inducible nitric oxide synthase expression by affecting interleukin-1 receptor and CCAAT/enhancer-binding protein β.

Authors:  Yuko Yamauchi; Tetsuya Okuyama; Toshinari Ishii; Tadayoshi Okumura; Yukinobu Ikeya; Mikio Nishizawa
Journal:  J Nat Med       Date:  2018-11-22       Impact factor: 2.343

Review 3.  Perilla frutescens: A Rich Source of Pharmacological Active Compounds.

Authors:  Tianyu Hou; Vasudeva Reddy Netala; Hongjiao Zhang; Yun Xing; Huizhen Li; Zhijun Zhang
Journal:  Molecules       Date:  2022-06-02       Impact factor: 4.927

4.  Comparative analysis of the constituents in Saposhnikoviae Radix and Glehniae Radix cum Rhizoma by monitoring inhibitory activity of nitric oxide production.

Authors:  Takuya Kamino; Toshihiro Shimokura; Yusuke Morita; Yasuhiro Tezuka; Mikio Nishizawa; Ken Tanaka
Journal:  J Nat Med       Date:  2016-02-01       Impact factor: 2.343

5.  The constituents of licorice (Glycyrrhiza uralensis) differentially suppress nitric oxide production in interleukin-1β-treated hepatocytes.

Authors:  Ryunosuke Tanemoto; Tetsuya Okuyama; Hirotaka Matsuo; Tadayoshi Okumura; Yukinobu Ikeya; Mikio Nishizawa
Journal:  Biochem Biophys Rep       Date:  2015-06-15

6.  Preparative Separation of Three Monoterpenes from Perilla frutescens var. crispa Using Centrifugal Partition Chromatography.

Authors:  Bomi Nam; Sunil Babu Paudel; Jin-Baek Kim; Chang Hyun Jin; Dongho Lee; Joo-Won Nam; Ah-Reum Han
Journal:  Int J Anal Chem       Date:  2019-01-09       Impact factor: 1.885

Review 7.  Exploring the Pivotal Immunomodulatory and Anti-Inflammatory Potentials of Glycyrrhizic and Glycyrrhetinic Acids.

Authors:  Seidu A Richard
Journal:  Mediators Inflamm       Date:  2021-01-07       Impact factor: 4.711

8.  A New Monoterpene from the Leaves of a Radiation Mutant Cultivar of Perilla frutescens var. crispa with Inhibitory Activity on LPS-Induced NO Production.

Authors:  Bomi Nam; Yangkang So; Hyo-Young Kim; Jin-Baek Kim; Chang Hyun Jin; Ah-Reum Han
Journal:  Molecules       Date:  2017-09-04       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.